BAD and endometrial cancer: We and others have demonstrated that the expression of the BAD-mediated apoptotic pathway and the phosphorylation status of the BAD protein influence the chemosensitivity of cancer cells, including ovarian and endometrial cancer cells (3,4,6,14).